Data2Discovery is mentioned in this comprehensive list of startups using AI in drug discovery, curated by BenchSci, the world's most comprehensive AI-driven biomedical discovery platform, backed by Google’s AI fund.
In March 2017, Data2Discovery was awarded a $750,000 grant from the National Science Foundation (NSF) via the highly competitive Small Business Innovation Research (SBIR) Phase II program. The grant will support Data2Discovery's efforts to support translational and phenotypic research on vast interlinked datasets; which will include applications in Drug Repurposing, Toxicology and Safety, and Phenotypic Analysis.
The Open PHACTS Foundation is pleased to formally announce the recent collaboration with Data2Discovery to form a Strategic Partnership. The goals of the partnership will support and continue with the Open PHACTS vision of creating a sustainable, open, interoperable information infrastructure for applied life science research and development, while advancing science for the public benefit through shared knowledge and data in life science and biomedical research.
In an innovative partnership with the NIH National Center for Advancing Translational Sciences (NCATS), and the OpenPHACTS foundation in the U.K., Data2Discovery Inc has applied its P3 graph-based association finding approach to identify 14 potential drug repurposing opportunities for TB.